ClearPoint Neuro Announces FDA Clearance for Software Versio

ClearPoint Neuro Announces FDA Clearance for Software Version 2.1

19.09.2022 - SOLANA BEACH, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) - ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has obtained 510(k) ... Seite 1

Related Keywords

Tim Orr , Software Engineering At Clearpoint Neuro , Clearpoint Pathfinder Program , Clearpoint Neuro , Vice President , Software Engineering ,

© 2025 Vimarsana